Expressions of ZEB2 and C-myc in epithelial ovarian cancer and their clinical significance
10.3969/j.issn.1673-4254.2015.12.20
- VernacularTitle:上皮性卵巢癌中ZEB2和C-myc蛋白的表达及临床意义
- Author:
Qinghai WANG
1
;
Huiping JIANG
;
Xiaojie DENG
;
Weiyi FANG
;
Suiqun GUO
Author Information
1. 南方医科大学1第三附属医院妇产科
- Keywords:
epithelial ovarian cancer;
ZEB2;
C-myc;
immunohistochemistry
- From:
Journal of Southern Medical University
2015;(12):1765-1769
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression patterns of ZEB2 and C-myc in epithelial ovarian cancer (EOC) and the associations between their expressions and the pathological features of EOC. Methods The expressions of ZEB2 and C-myc proteins were detected immunohistochemically in 191 cervical cancer tissues and 13 normal ovarian tissues. The relationship between ZEB2 and C-myc protein expressions and the clinicopathological features of EOC was evaluated. Results ZEB2 positive expression ratea in EOC tissues and normal ovarian tissues were 49.2% (94/191) and 30.8% (4/13), respectively (P=0.007), and C-myc positive expression rates in the two tissues were 53.9%(103/191) and 15.4%(2/13), respectively (P=0.001). A high expression of ZEB2 was positively correlated with the pathological type of the tumor (P=0.003), FIGO stage (P=0.028), T stage (P=0.002), and N stage (P=0.04), and a high expression of C-myc was positively correlated with FIGO stage (P=0.035), histological grade (P=0.039), and T stage (P=0.002). C-myc and ZEB2 expressions were positively correlated in EOC (P<0.001), and their co-expression in EOC was significantly correlated with T stage (R=0.358, P<0.001) and FIGO stage (P=0.008). Conclusion ZEB2 and C-myc can promote the progression, invasion and metastasis of EOC, and their combined detection may assist in early diagnosis of EOC.
